FDA Adverse Event Injury Summary report: N

FLEXTEND II

MDR report key: 3053653 · Received April 11, 2013

Report

Report Number
2124215-2013-05291
Event Type
Injury
Date Received
April 11, 2013
Date of Event
January 1, 2013
Report Date
March 28, 2013
Manufacturer
GUIDANT PUERTO RICO BV
Product Code
NVN
PMA / PMN Number
NOTAPVD
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ACCORDING TO AVAILABLE INFORMATION, NO RETURN OF PRODUCT IS INTENDED. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS ATRIAL LEAD DISLODGED. A REVISION PROCEDURE WAS PERFORMED. THIS LEAD WAS REMOVED AND NOT REPLACED AS THE PATIENT IS IN ATRIAL FIBRILLATION. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
156820 FLEXTEND II IMPLANTABLE LEAD NVN GUIDANT PUERTO RICO BV 4097

Patients

Seq Age Sex Outcome Treatment
1 76 YR Hospitalization| L| R 0950| 0465| (B)(4)| 1283| 4285